FDA Brief

Warning letters Drugs

FDA warning letter to

Boiron, Inc.

High riskIssued Sep 11, 2023Posted Sep 12, 2023Center for Drug Evaluation and Research | CDER

FDA warns Boiron that Optique 1 Eye Drops are an unapproved new drug sold with drug claims.

What happened

FDA reviewed Boiron's website and Facebook/Instagram pages in July 2023. FDA found that the sites offered Optique 1 Eye Drops for sale and included claims that the product relieves eye irritation, dry eyes, allergies, and eyestrain. FDA concluded the product is a drug and an unapproved new drug because it is not generally recognized as safe and effective and has no FDA-approved application.

What FDA found

  1. Website and social media claims show Optique 1 Eye Drops are intended to treat eye irritation, allergies, and eyestrain, so FDA treats the product as a drug.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. The eye drops are a 'new drug' because they are not generally recognized as safe and effective for the claimed uses.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. No FDA-approved application is in effect for Optique 1 Eye Drops, so selling it in interstate commerce violates the FD&C Act.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  4. Labeling the product as homeopathic does not exempt it from drug approval, misbranding, or adulteration requirements.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)

What FDA wants

FDA asks Boiron to notify FDA in writing within fifteen working days of receipt of the steps taken to correct the violations and prevent recurrence, with related documentation. If Boiron cannot complete corrective action in that time, it must state the reason and when it will finish.

Who should pay attention

  • retailers and online marketplaces selling Boiron eye drops
  • consumers using homeopathic eye drops
  • companies marketing homeopathic drugs with disease claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk